- Release Date: 17/12/19 09:29
- Summary: CHF P3 Trial Accrues Sufficient Primary Endpoint Events
- Price Sensitive: Yes
- Download Document 122.57KB
- Forums
- ASX - By Stock
- MSB
- Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events
MSB
mesoblast limited
Add to My Watchlist
0.22%
!
$2.29

Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.29 |
Change
-0.005(0.22%) |
Mkt cap ! $2.918B |
Open | High | Low | Value | Volume |
$2.26 | $2.31 | $2.25 | $3.258M | 1.425M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 19525 | $2.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.29 | 108116 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 16272 | 2.280 |
29 | 121947 | 2.270 |
18 | 190424 | 2.260 |
34 | 195429 | 2.250 |
19 | 279930 | 2.240 |
Price($) | Vol. | No. |
---|---|---|
2.290 | 107633 | 20 |
2.300 | 150758 | 22 |
2.310 | 122478 | 14 |
2.320 | 92007 | 12 |
2.330 | 133658 | 12 |
Last trade - 15.01pm 12/08/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |